InstalabHepatitis Panel
Should you take a Hepatitis Panel test?
This test is most useful if any of these apply to you.
5 biomarkers included
- Total Hepatitis A AntibodyShows whether you carry immunity to hepatitis A from past infection or vaccination, giving a fast read on your protection against this food- and water-borne virus.Why it mattersA negative result means no protection against hepatitis A, marking you as a candidate for vaccination before travel or exposure.
- Hepatitis B Surface AntibodyMeasures your protection against hepatitis B. It rises after vaccination or recovery, and at a high enough level it means you are shielded from infection.Why it mattersA protective level confirms immunity; its absence in an unexposed person means you are still vulnerable and should be vaccinated.
- Hepatitis B Surface AntigenThe direct marker of active hepatitis B. When it is present, the virus is currently in your body and replicating, whether the infection is new or has quietly persisted for years.Why it mattersA positive result means active hepatitis B that needs confirmation, staging, and screening for liver cancer.
- Hepatitis B Core Antibody TotalAppears only after a real hepatitis B infection and never from a vaccine. It reveals whether you have ever encountered the virus, even when other markers have faded.Why it mattersA positive result means natural hepatitis B exposure, and alone can signal a hidden infection needing a viral load check.
- Hepatitis C AntibodyScreens for any past or present contact with hepatitis C. Because it stays positive for life, it identifies who needs a follow-up test to confirm whether the virus is still active.Why it mattersA positive result signals hepatitis C exposure and triggers a viral test, since antibody alone cannot prove current infection.
About Hepatitis Panel
Hepatitis B and C can live in your liver for decades without a single symptom, quietly scarring it while everything feels fine. By the time they announce themselves, the damage can already be cirrhosis or liver cancer. This panel is built to find them long before that point.
In one blood draw, it answers three questions no single test can settle alone: whether a liver virus is active in you right now, whether you have been exposed to one before, and whether you are actually protected. It also shows whether you still lack immunity to two vaccine-preventable viruses, so you know exactly where you stand.
What This Panel Reveals
The most urgent question is whether a virus is replicating in your liver at this moment. For hepatitis B, one marker answers it directly: a piece of the virus's outer shell called the surface antigen. If it is present, the infection is active, whether it is brand new or has persisted quietly for years. The hepatitis C antibody flags contact with hepatitis C, but because it stays positive for life even after the virus clears, a positive result points to a needed follow-up rather than a final verdict.
Two other antibodies map where you have already been. The hepatitis B core antibody appears only after a real, natural infection and never from a vaccine, so it separates people who have met the virus from those who were only immunized. The total hepatitis A antibody is different: it confirms immunity to hepatitis A but cannot tell whether that protection came from a past infection or a vaccine, since both produce the same antibody.
The last marker measures protection. The hepatitis B surface antibody rises after successful vaccination or recovery, and a high enough level means you are shielded from infection. Read next to the core antibody, it reveals whether that shield came from a shot or from surviving an actual infection. Together the five markers turn scattered clues into a single clear status.
How to Read Your Results Together
The value of this panel is in the combinations. The same negative or positive marker means very different things depending on what sits beside it, and a handful of patterns cover most people.
| Your marker pattern | What it most likely means |
|---|---|
| Surface antigen positive, core antibody positive | Active hepatitis B infection; confirm with a viral load test and begin liver monitoring |
| Surface antibody positive, core antibody negative | Protected by vaccination, with no sign of past or current infection |
| Surface antigen negative, surface antibody positive, core antibody positive | A past hepatitis B infection your body cleared, leaving you immune |
| Core antibody positive by itself | An isolated pattern that needs a viral load test to rule out a hidden infection |
Hepatitis C follows its own rule. A positive antibody cannot tell active infection from one that has already resolved or been cured, so it must be confirmed with a test that detects the virus's genetic material (called HCV RNA). Whether that shield of surface antibody is present also carries real weight: people who cleared hepatitis B but kept the surface antibody had the virus reawaken far less often during immune-suppressing treatment, about 5.0% of the time versus 14% in those with the core antibody alone.
What to Do with Your Results
A positive surface antigen means active hepatitis B and warrants a viral load test, a liver specialist, and ongoing screening for liver cancer, because chronic infection carries roughly a nine-fold higher risk of it. A positive hepatitis C antibody warrants a genetic-material test to confirm current infection. If the virus is still active, modern direct-acting antiviral pills cure more than 95% of cases, and among people who reach a cure versus those who do not, cure is linked to about a 71% lower risk of liver cancer and a 60% lower risk of death from any cause.
A different outcome deserves attention too: all hepatitis B markers negative. That means you are neither infected nor protected, a position an estimated 73.4% of U.S. adults age 25 and older still occupy. The clear next step is vaccination for hepatitis B, and for hepatitis A if that antibody is also negative.
For serial tracking, most people who test negative and are vaccinated need this panel only once, unless a new exposure arises. If you carry a chronic infection, you shift instead to regular monitoring of the virus and your liver, where changes between draws guide treatment timing and cancer surveillance.
When Results Can Be Misleading
The biggest panel-wide trap is timing. After a recent exposure, antibodies may not have formed yet, so a clean screen drawn too soon does not rule out infection. This window can last weeks to months for hepatitis C, which is why a negative result shortly after a possible exposure should be repeated.
The second trap is treating an antibody as proof of active virus. The surface antigen genuinely confirms active hepatitis B, but the hepatitis C antibody only marks exposure and needs a genetic-material test to confirm infection. Weak positive antibody results are also more common in people at low risk, another reason a single reactive marker is a prompt to confirm, not a diagnosis.